Scholarlink

Background <p>Eosinophilic esophagitis (EoE) shares several risk factors with other autoimmune diseases, but population-based studies in this field are limited.</p> Methods <p>Using the Swedish nationwide histopathology cohort Epidemiology Strengthened by histopathology Reports in Sweden (ESPRESSO), we identified all patients in Sweden with EoE and matched them by age, sex, county of residence and calendar year with up to 5 general population reference individuals. Using Cox regression modelling, we calculated hazard ratios (HRs) for future autoimmune disease as recorded in the National Patient Register. Using conditional logistic regression, we also calculated odds ratios (ORs) for autoimmune disease prior to EoE.</p> Results <p>We identified 1477 individuals with EoE and 6933 matched reference individuals from the general population. During a median follow-up of 8 years, 44 EoE patients (2.98%) and 113 reference individuals (1.63%) developed autoimmune disease with incidence rates of 3.54 and 1.93 per 1000 person-years, respectively. The adjusted HR for subsequent autoimmune disease was 1.83 (95% CI = 1.29–2.59) among patients with EoE compared to general population reference individuals. Excluding inflammatory bowel disease and celiac disease from our composite outcome, the adjusted HR for non-gastrointestinal autoimmunity was 1.45 (95% CI = 0.93–2.25). EoE was also associated with earlier autoimmune disease with 7.9% of EoE patients having a record of an autoimmune disease before EoE, as compared with 2.9% of reference individuals (OR = 2.92; 95% CI = 2.34–3.65).</p> Conclusion <p>EoE was associated with both antecedent and subsequent autoimmune disease, which was strongly driven by gastrointestinal autoimmune conditions. While associations with non-gastrointestinal autoimmune diseases did not reach statistical significance in the present analysis, they warrant further investigation. Clinicians treating patients with EoE should be aware of the increased risk of concomitant or future autoimmunity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bidirectional risk of autoimmune disease and eosinophilic esophagitis in Sweden

  • 期刊论文

  • 发表日期：

    2026年5月21日

查看全文
  • Ashley L. Pyne,
  • Amiko M. Uchida,
  • Marie Carlson,
  • David Bergman,
  • Kathryn A. Peterson,
  • Soran R. Bozorg,
  • John J. Garber,
  • Bjorn Roelstraete,
  • Jonas F. Ludvigsson

摘要

Background

Eosinophilic esophagitis (EoE) shares several risk factors with other autoimmune diseases, but population-based studies in this field are limited.

Methods

Using the Swedish nationwide histopathology cohort Epidemiology Strengthened by histopathology Reports in Sweden (ESPRESSO), we identified all patients in Sweden with EoE and matched them by age, sex, county of residence and calendar year with up to 5 general population reference individuals. Using Cox regression modelling, we calculated hazard ratios (HRs) for future autoimmune disease as recorded in the National Patient Register. Using conditional logistic regression, we also calculated odds ratios (ORs) for autoimmune disease prior to EoE.

Results

We identified 1477 individuals with EoE and 6933 matched reference individuals from the general population. During a median follow-up of 8 years, 44 EoE patients (2.98%) and 113 reference individuals (1.63%) developed autoimmune disease with incidence rates of 3.54 and 1.93 per 1000 person-years, respectively. The adjusted HR for subsequent autoimmune disease was 1.83 (95% CI = 1.29–2.59) among patients with EoE compared to general population reference individuals. Excluding inflammatory bowel disease and celiac disease from our composite outcome, the adjusted HR for non-gastrointestinal autoimmunity was 1.45 (95% CI = 0.93–2.25). EoE was also associated with earlier autoimmune disease with 7.9% of EoE patients having a record of an autoimmune disease before EoE, as compared with 2.9% of reference individuals (OR = 2.92; 95% CI = 2.34–3.65).

Conclusion

EoE was associated with both antecedent and subsequent autoimmune disease, which was strongly driven by gastrointestinal autoimmune conditions. While associations with non-gastrointestinal autoimmune diseases did not reach statistical significance in the present analysis, they warrant further investigation. Clinicians treating patients with EoE should be aware of the increased risk of concomitant or future autoimmunity.